Tag:
Value Capital Partners
Ghost Bites
Ghost Bites Vol 42 (22)
There's some relief for Nampak and Aveng shareholders, even though both share prices hardly noticed. Blue Label has made progress with Cell C. Alphamin's quarter-on-quarter results are tough.